Pfizer Raises Stake In NRGN To 21%

Pfizer raises stake in NRGN to 21%

Pfizer Inc. increased its commitment to Neurogen Corp. (NRGN), entering into a second agreement to develop central nervous system drugs. The

Read the full 283 word article

How to gain access

Continue reading with a
two-week free trial.